GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Huapont Life Science Co Ltd (SZSE:002004) » Definitions » Cyclically Adjusted Revenue per Share

Huapont Life Science Co (SZSE:002004) Cyclically Adjusted Revenue per Share : ¥5.27 (As of Mar. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Huapont Life Science Co Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Huapont Life Science Co's adjusted revenue per share for the three months ended in Mar. 2024 was ¥1.473. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ¥5.27 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Huapont Life Science Co's average Cyclically Adjusted Revenue Growth Rate was 4.20% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 7.30% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 10.70% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 16.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Huapont Life Science Co was 25.30% per year. The lowest was 7.30% per year. And the median was 19.00% per year.

As of today (2024-06-05), Huapont Life Science Co's current stock price is ¥4.36. Huapont Life Science Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ¥5.27. Huapont Life Science Co's Cyclically Adjusted PS Ratio of today is 0.83.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Huapont Life Science Co was 11.52. The lowest was 0.79. And the median was 1.73.


Huapont Life Science Co Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Huapont Life Science Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Huapont Life Science Co Cyclically Adjusted Revenue per Share Chart

Huapont Life Science Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.71 4.20 4.81 5.00 5.19

Huapont Life Science Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.06 5.08 5.18 5.19 5.27

Competitive Comparison of Huapont Life Science Co's Cyclically Adjusted Revenue per Share

For the Agricultural Inputs subindustry, Huapont Life Science Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Huapont Life Science Co's Cyclically Adjusted PS Ratio Distribution in the Agriculture Industry

For the Agriculture industry and Basic Materials sector, Huapont Life Science Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Huapont Life Science Co's Cyclically Adjusted PS Ratio falls into.



Huapont Life Science Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Huapont Life Science Co's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.473/115.2271*115.2271
=1.473

Current CPI (Mar. 2024) = 115.2271.

Huapont Life Science Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 1.003 98.200 1.177
201409 0.691 98.900 0.805
201412 0.822 99.000 0.957
201503 0.800 99.900 0.923
201506 0.951 99.500 1.101
201509 0.737 100.500 0.845
201512 0.734 100.600 0.841
201603 0.702 102.200 0.791
201606 0.910 101.400 1.034
201609 0.833 102.400 0.937
201612 1.072 102.600 1.204
201703 0.977 103.200 1.091
201706 1.071 103.100 1.197
201709 0.876 104.100 0.970
201712 1.465 104.500 1.615
201803 1.402 105.300 1.534
201806 1.064 104.900 1.169
201809 1.419 106.600 1.534
201812 1.357 106.500 1.468
201903 1.226 107.700 1.312
201906 1.319 107.700 1.411
201909 1.290 109.800 1.354
201912 1.206 111.200 1.250
202003 1.088 112.300 1.116
202006 1.542 110.400 1.609
202009 1.379 111.700 1.423
202012 1.517 111.500 1.568
202103 1.424 112.662 1.456
202106 1.479 111.769 1.525
202109 1.455 112.215 1.494
202112 1.921 113.108 1.957
202203 1.717 114.335 1.730
202206 1.666 114.558 1.676
202209 1.758 115.339 1.756
202212 1.541 115.116 1.542
202303 1.503 115.116 1.504
202306 1.460 114.558 1.469
202309 1.507 115.339 1.506
202312 1.385 114.781 1.390
202403 1.473 115.227 1.473

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Huapont Life Science Co  (SZSE:002004) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Huapont Life Science Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=4.36/5.27
=0.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Huapont Life Science Co was 11.52. The lowest was 0.79. And the median was 1.73.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Huapont Life Science Co Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Huapont Life Science Co's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Huapont Life Science Co (SZSE:002004) Business Description

Traded in Other Exchanges
N/A
Address
No. 69, Renhe Xingguang Avenue, Yubei District, Chongqing, CHN, 401121
Huapont Life Science Co Ltd is a China-based company engaged in the manufacturing and distribution of pharmaceutical products. In addition, the company is also engaged in the agrochemical business and medical business. The agrochemical department is mainly engaged in the research and development, production, sales, and technical services of pesticide intermediates, original drugs, and preparations.
Executives
Zhang Hai An Directors, executives
Wang Rong Director
Yu Jun Tian Director
Zhang Song Shan Directors, executives
Chen Zhi Securities Affairs Representative
Jiang Kang Wei Director
Lv Li Ming Director
Li Sheng Xue Director
Luo Da Lin Supervisors
Li Zhi Directors, executives
Tian Song Min Executives
Wu Bi Zhong Director
Yu Yun Jian Supervisors
Gu Chuan Wei Supervisors

Huapont Life Science Co (SZSE:002004) Headlines

No Headlines